Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This is a combination therapy consisting of oxycodone (an opioid analgesic) and parecoxib sodium (a selective COX-2 inhibitor). The combination represents a multimodal analgesic approach for managing postoperative pain. Parecoxib sodium is a water-soluble injectable prodrug of valdecoxib that provides anti-inflammatory, analgesic, and antipyretic effects through selective inhibition of COX-2[2][4]. Oxycodone acts on the central nervous system to relieve pain[3]. When used together, this combination can provide effective pain relief while potentially reducing opioid consumption and opioid-related adverse effects[6][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on oxycodone + parecoxib sodium.